Irina Bancos is an Endocrinology/Metabolic physician. ClinicalTrials.gov lists 5 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
200 1st St SW
Rochester, MN 559050001
Telephone
507-284-2511Provider last certified this registry record 12 Aug 2020.
Clinical trials
- Impact of 1 mg Osilodrostat Therapy on Mild Autonomous Cortisol Secretion (MACS)
Sponsor: Mayo Clinic
- Metyrapone for Mild Autonomous Cortisol Secretion (MACS)
Sponsor: Mayo Clinic
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
11 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Neurocrine BioSciences, Inc.Program year202516 payments$11,533openpaymentsdata.cms.gov ↗
- RECORDATI_RARE_DISEASES_INC.Program year20256 payments
- AstraZeneca Pharmaceuticals LPProgram year202510 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
43.8%Corticosteroid43.8%Hydrocortisone49%Dexamethasone37%Dexamethasone Sodium Phosphate14%Part D≥39 patientsHormonal (systemic)
31.3%l-Thyroxine16.9%Levothyroxine Sodium100%Part D≥15 patientsMineralocorticoids9.6%Fludrocortisone Acetate100%Part D<11 patients+ 1 more class in this area
Metabolism & gastrointestinal
12.8%Corticosteroid12.8%Prednisone100%Part D≥15 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
4 NIH research awards on record, funded 2019–2026 per NIH RePORTER. The latest:
- Reversing abnormal metabolism in mild autonomous cortisol secretion (MACS)
Mayo Clinic Rochester
FY2026$741,387R01DK145578 - Impact of menopause associated adrenal aging on cognitive function and Alzheimer dementia neuroimaging biomarkers
Mayo Clinic Rochester
FY2023$154,376R03AG071934 - Impact of abnormal steroid metabolome on cellular senescence, frailty and cognition
Mayo Clinic Rochester
FY2023$119,250R03DK132121
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Bruce Bartholow Duncan
Universidade Federal do Rio Grande do Sul
Alireza Esteghamati
Tehran University of Medical Sciences
Paul Zimmet
Monash University
André Pascal Kengne
South African Medical Research Council
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”